Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Exercise therapy for an older patient with left ventricular assist device.

Park WH, Seo YG, Sung JD.

Ann Rehabil Med. 2014 Jun;38(3):396-400. doi: 10.5535/arm.2014.38.3.396. Epub 2014 Jun 26.

2.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.

3.

The successful implantation of continuous-flow left ventricular assist device as a destination therapy in Korea: echocardiographic assessment.

Lee GY, Park SJ, Kim S, Choi N, Jeong DS, Jeon ES, Lee YT.

J Korean Med Sci. 2014 Jan;29(1):137-40. doi: 10.3346/jkms.2014.29.1.137. Epub 2013 Dec 26.

4.
5.

Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.

Compostella L, Russo N, Setzu T, Compostella C, Bellotto F.

Artif Organs. 2014 May;38(5):366-73. doi: 10.1111/aor.12172. Epub 2013 Oct 1.

PMID:
24117945
6.

Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands.

Haeck ML, Beeres SL, Höke U, Palmen M, Couperus LE, Delgado V, Logeman EA, Maas JJ, Klautz RJ, Schalij MJ, Verwey HF.

Neth Heart J. 2015 Feb;23(2):102-8. doi: 10.1007/s12471-014-0602-4.

7.

Ethical challenges with the left ventricular assist device as a destination therapy.

Rizzieri AG, Verheijde JL, Rady MY, McGregor JL.

Philos Ethics Humanit Med. 2008 Aug 11;3:20. doi: 10.1186/1747-5341-3-20.

8.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

10.

Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2016 Feb 8;16(3):1-60. eCollection 2016 Feb 8. Review.

11.

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.

Circulation. 1994 Nov;90(5 Pt 2):II83-6.

PMID:
7955290
12.

Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure: Eight-year experience with the implantable HeartMate LVAS.

Lahpor JR, de Jonge N, van Swieten HA, Wesenhagen H, Klöpping C, Geertman JH, Oosterom A, Rodermans B, Kirkels JH.

Neth Heart J. 2002 Jun;10(6):267-271.

13.
14.

Improving outcomes with long-term "destination" therapy using left ventricular assist devices.

Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, Clayson SE, Reid BB, Moore SA, Blank DU, Renlund DG.

J Thorac Cardiovasc Surg. 2008 Jun;135(6):1353-60; discussion 1360-1. doi: 10.1016/j.jtcvs.2006.09.124.

15.

Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.

Jaski BE, Lingle RJ, Kim J, Branch KR, Goldsmith R, Johnson MR, Lahpor JR, Icenogle TB, Piña I, Adamson R, Favrot LK, Dembitsky WP.

J Heart Lung Transplant. 1999 Nov;18(11):1031-40.

PMID:
10598726
16.

Assessment of submaximal exercise capacity in patients with left ventricular assist devices.

Foray A, Williams D, Reemtsma K, Oz M, Mancini D.

Circulation. 1996 Nov 1;94(9 Suppl):II222-6.

PMID:
8901750
17.

Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.

Tsiouris A, Paone G, Nemeh HW, Borgi J, Williams CT, Lanfear DE, Morgan JA.

World J Cardiol. 2015 Nov 26;7(11):792-800. doi: 10.4330/wjc.v7.i11.792.

18.

Initial 3-year outcomes with left ventricular assist devices in a country with a nascent heart transplantation program.

Pya Y, Bekbossynova M, Jetybayeva S, Bekbossynov S, Andossova S, Salov R, Medressova A, Novikova S, Murzagaliyev M.

ESC Heart Fail. 2016 Mar;3(1):26-34. Epub 2015 Oct 30.

19.

Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.

Miyagawa S, Toda K, Nakamura T, Yoshikawa Y, Fukushima S, Saito S, Yoshioka D, Saito T, Sawa Y.

Surg Today. 2016 Feb;46(2):149-54. doi: 10.1007/s00595-015-1149-8. Epub 2015 Apr 4. Review.

PMID:
25840890
20.

Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy?

Alsara O, Perez-Terzic C, Squires RW, Dandamudi S, Miranda WR, Park SJ, Thomas RJ.

J Cardiopulm Rehabil Prev. 2014 Jul-Aug;34(4):233-40. doi: 10.1097/HCR.0000000000000050. Review.

PMID:
24531204

Supplemental Content

Support Center